Pesquisar
Emergent BioSolutions Inc
EBSAdicionar à lista de desejos
6.800USD
-0.220-3.13%
Fechamento 09-18 16:00（ET）
347.81MValor de mercado
PerdaP/L TTM
Após o expediente 19:00 (ET)6.800USD-0.030-0.44%
Após o expediente 19:00 (ET)Mais detalhes de Emergent BioSolutions Inc Empresa
Emergent BioSolutions, Inc. is a life sciences company. It is focused on providing preparedness and response solutions addressing accidental, deliberate and naturally occurring public health threats. Its solutions include a product portfolio, a product development portfolio, and a contract development and manufacturing services portfolio. Its segments include Commercial Products, MCM Products, and Services segment. Its Commercial Product segment consists of NARCAN Nasal Spray. Its MCM Products segment consists of Anthrax MCM products, Smallpox MCM products and Other Products. Its Services segment consists of its Bioservices portfolio. NARCAN (naloxone HCl) Nasal Spray, an intranasal formulation of naloxone, is developed for the emergency treatment of known or suspected opioid overdose as manifested by respiratory and central nervous system depression. Its Bioservices consist of development services, bulk drug substance manufacturing, fill, finish, and packaging of final drug products.
Emergent BioSolutions Inc Perfil
Código da empresaEBS
Nome da EmpresaEmergent BioSolutions Inc
Data de listagemNov 15, 2006
CEOPapa (Joseph C)
Número de funcionários900
Tipo de títulosOrdinary Share
Fim do ano fiscalNov 15
Endereço300 Professional Dr
CidadeGAITHERSBURG
Bolsa de valoresNASDAQ OMX NASDAQ Basic NYSE
PaísUnited States of America
Código postal20879
Telefone12406313200
Sitehttps://emergentbiosolutions.com/
Código da empresaEBS
Data de listagemNov 15, 2006
CEOPapa (Joseph C)
Executivos da empresa Emergent BioSolutions Inc
Nome
Nome/Posição
Posição
Ações detidas
Variação
Mr. Joseph C. (Joe) Papa
Mr. Joseph C. (Joe) Papa
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
304.82K
+61.58%
Mr. Joseph C. (Joe) Papa
Mr. Joseph C. (Joe) Papa
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
304.82K
+61.58%
Mr. Joseph C. (Joe) Papa
Mr. Joseph C. (Joe) Papa
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
304.82K
+61.58%
Mr. Richard S. (Rich) Lindahl
Mr. Richard S. (Rich) Lindahl
Chief Financial Officer, Executive Vice President
Chief Financial Officer, Executive Vice President
267.95K
-1.48%
Mr. Richard S. (Rich) Lindahl
Mr. Richard S. (Rich) Lindahl
Chief Financial Officer, Executive Vice President
Chief Financial Officer, Executive Vice President
267.95K
-1.48%
Mr. Richard S. (Rich) Lindahl
Mr. Richard S. (Rich) Lindahl
Chief Financial Officer, Executive Vice President
Chief Financial Officer, Executive Vice President
267.95K
-1.48%
Ms. Stephanie Duatschek
Ms. Stephanie Duatschek
Executive Vice President, Chief Growth Officer
Executive Vice President, Chief Growth Officer
197.42K
--
Ms. Stephanie Duatschek
Ms. Stephanie Duatschek
Executive Vice President, Chief Growth Officer
Executive Vice President, Chief Growth Officer
197.42K
--
Ms. Stephanie Duatschek
Ms. Stephanie Duatschek
Executive Vice President, Chief Growth Officer
Executive Vice President, Chief Growth Officer
197.42K
--
Ms. Jessica Perl
Ms. Jessica Perl
Senior Vice President, General Counsel, Corporate Secretary
Senior Vice President, General Counsel, Corporate Secretary
165.29K
+63.09%
Ver Mais
Nome
Nome/Posição
Posição
Ações detidas
Variação
Mr. Joseph C. (Joe) Papa
Mr. Joseph C. (Joe) Papa
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
304.82K
+61.58%
Mr. Joseph C. (Joe) Papa
Mr. Joseph C. (Joe) Papa
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
304.82K
+61.58%
Mr. Joseph C. (Joe) Papa
Mr. Joseph C. (Joe) Papa
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
304.82K
+61.58%
Mr. Richard S. (Rich) Lindahl
Mr. Richard S. (Rich) Lindahl
Chief Financial Officer, Executive Vice President
Chief Financial Officer, Executive Vice President
267.95K
-1.48%
Mr. Richard S. (Rich) Lindahl
Mr. Richard S. (Rich) Lindahl
Chief Financial Officer, Executive Vice President
Chief Financial Officer, Executive Vice President
267.95K
-1.48%
Mr. Richard S. (Rich) Lindahl
Mr. Richard S. (Rich) Lindahl
Chief Financial Officer, Executive Vice President
Chief Financial Officer, Executive Vice President
267.95K
-1.48%
Perguntas frequentes
Quem são os cinco principais acionistas de Emergent BioSolutions Inc?
Os cinco principais acionistas de Emergent BioSolutions Inc são: Mr. Joseph C. (Joe) Papa
Quantas instituições possuem ações da Emergent BioSolutions Inc (EBS)?
Em 2026Q1, 412 instituições possuíam ações da Emergent BioSolutions Inc, com valor de mercado aproximado de 42.30M, representando 81.98% do total de ações. Em comparação com 2025Q4, a participação institucional aumentou em -3370363.00.
Qual é a maior fonte de receita da Emergent BioSolutions Inc?
Em 2026Q1, o segmento de negócios MCM Product sales gerou a maior receita para Emergent BioSolutions Inc, totalizando 168.00M e representando 71.70% da receita total.